Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.81 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113383 | 1.00 | MAPK1 (0.81) | MAPK1MEN1KMT2ALMNACYP2C9 | |
| SCHEMBL6018054 | 1.00 | MAPK1 (0.81) | MAPK1MEN1KMT2ALMNACYP2C9 | |
| SCHEMBL20906278 | 1.00 | MAPK1 (0.81) | MAPK1MEN1KMT2ALMNACYP2C9 | |
| Hydrochloric Acid SCHEMBL989897 | 0.97 | MAPK1 (0.77) | MAPK1MEN1KMT2ALMNACYP2C9 | |
| SCHEMBL13908059 | 0.90 | MAPK1 (1.00) | MAPK1MEN1KMT2ACHRNA7 | |
| SCHEMBL551145 | 0.90 | MAPK1 (1.00) | MAPK1MEN1KMT2ACHRNA7 | |
| Hydrochloric Acid SCHEMBL934612 | 0.87 | MAPK1 (0.95) | MAPK1MEN1KMT2A | |
| Carbamic Acid SCHEMBL12615819 | 0.87 | MAPK1 (0.63) | MAPK1MEN1KMT2ALMNACYP2C9 | |
| SCHEMBL23086048 | 0.85 | MAPK1 (0.61) | MAPK1MEN1KMT2ALMNACYP2C9 | |
| SCHEMBL12593647 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1613 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540913-B2 | Chemical sensor, reagent, and method for detecting benzoic acid and benzoic acid derivative | KABUSHIKI KAISHA TOSHIBA (JP) | 2026-02-03 | — | — | US | claimed |
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| US-12486263-B2 | Method for the preparation of n-monofluoroalkyl tropanes and their use | ROTOP RADIOPHARMACY GMBH (DE) | 2025-12-02 | — | — | US | claimed |
| US-12480131-B2 | Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-11-25 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| CN-120160884-A | Method for detecting granular organic nitrate in soil | 石河子大学 | 2025-06-17 | — | — | CN | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-12317576-B2 | Method for forming a semiconductor structure using dehydrating chemical, and method for forming a semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD. (TW) | 2025-05-27 | — | — | US | claimed |
| CN-115960103-B | Torpedoyl conjugated ketene derivative and preparation method and application thereof | 北京化工大学 | 2025-03-18 | — | — | CN | claimed |
| EP-0915150-A1 | Processes of soaking fabrics with a liquid aqueous persulfate salt-containing composition | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-12 | — | — | EP | claimed |
| EP-0913462-A1 | Liquid aqueous bleaching compositions packaged in a UV-resistant container | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| EP-0913515-A1 | Process of bleaching fabrics | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| EP-0913463-A1 | Multi-purpose liquid aqueous bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| US-5759727-A | TONER IMAGE ON TRANSPARENT SUBSTRATE; MELT POLYMER BACKING | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0085892-B1 | SUBSTITUTED BENZODIAZEPINONES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1985-12-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486263-B2 | Method for the preparation of n-monofluoroalkyl tropanes and their use | TTPA, MTTP, TBXA2R | MAPK1 4145/4885MEN1 1024/4885KMT2A 4334/4885 |
| US-12540913-B2 | Chemical sensor, reagent, and method for detecting benzoic acid and benzoic acid derivative | CES2, ALKBH1, ALKBH5 | MAPK1 468/4885MEN1 4656/4885KMT2A 704/4885 |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | SQSTM1, BECN1, CUTA | MAPK1 2768/4885MEN1 3254/4885KMT2A 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.